Fulgent Genetics, Inc. (FLGT) stock price moved 4.53% away from 20-Days Simple Moving Average, 7.42% from 50-Days Simple Moving Average and separated -4.38% from 200 Days Simple Moving Average. Fulgent Genetics, Inc. (FLGT) reported loss -11.35% in recent buying and selling session with closing price of $ 3.75. The stock’s traded 0.14 million shares in session while it holds an average volume of 0.02 million shares. The FLGT switched 24.17% away from its 52 week minimum and distanced -32.55% from its 52 week peak. The volatility change in the previous week has observed by 22.69% and experienced of 11.92% change in the last month.
The short ratio in the company’s stock is documented at 0.82 and the short float is around of 0.33%. The Company kept a record of 5.51 million floated shares and 20.37 million shares outstanding. The average true range of the stock is observed at 0.50 and the relative strength index of the stock is recorded at 50.76.
Fulgent Genetics, Inc. (FLGT) Stock Profitability Levels:
Net profit margin of the company is seen at -25.90%. Operating profit margin is positioned at -30.40%. Gross profit margin is 47.50%. The larger the gross profit margin, the better for the company. The company made Return on equity of -9.80% in last 12 months period. Return on assets ratio of the Company was -9.30%. Its return on investment ratio was -4.50% in the trailing 12 months period.
Looking out over a next 5-year period, analysts expect the company to see its earnings go up by 32.68%, annually. Analyst established EPS growth expected to grow of 64.30% for this year and EPS growth for next year is likely to attain at 130.00%.
Looking about the past performance history, the company plunged -6.48% for the last five trades and expanded 11.28% in one month period. The stock deteriorated -3.85% during the past three month period and discounted -8.54% in half year. During the yearly overview it downgraded -11.24% and shown 18.30% year to date performance.